The Calnexin/Calreticulin Cycle: Ensuring Glycoprotein…

What is the Calnexin/Calreticulin Cycle?

The calnexin/calreticulin cycle is a fundamental process that occurs within the endoplasmic reticulum (ER) of eukaryotic cells. This cycle plays a crucial role in ensuring proper glycoprotein folding by binding to monoglucosylated N-glycans, facilitating their folding and refolding processes.

Calnexin and calreticulin are lectins that recognize specific carbohydrate structures on nascent polypeptides as they exit the ER. This interaction helps maintain the correct conformation of the protein until it is fully folded or marked for degradation.

How Does It Work?

Monoglucosylated N-glycans, which are partially folded glycoproteins, bind to calnexin and calreticulin. These chaperone proteins provide a stable environment for the correct folding of the protein by maintaining its conformation through their carbohydrate-binding domains.

If the protein fails to fold correctly after multiple attempts, it is released from the cycle and undergoes further processing in the ER-associated degradation (ERAD) pathway. UGGT (UDP-Glc:Glycoprotein Glc-Transferase) re-glucosylates these proteins for another round of folding attempts.

live demo · related simulation● LIVE

Why Is It Important?

Proper glycoprotein folding is essential for the function and stability of many cellular processes. Misfolded or improperly processed glycoproteins can lead to a variety of diseases, including neurodegenerative disorders, diabetes, and cancer.

The calnexin/calreticulin cycle ensures that only correctly folded proteins are released from the ER into the secretory pathway, thereby maintaining protein quality and cellular homeostasis.

Real-World Applications

Understanding the calnexin/calreticulin cycle has significant implications for drug development and disease treatment. For instance, targeting this cycle could provide new strategies to enhance protein folding in patients with genetic disorders or neurodegenerative diseases.

Additionally, manipulating this cycle may offer insights into improving vaccine efficacy by ensuring that only properly folded antigens are presented to the immune system.

Frequently asked questions

What happens if a protein cannot be refolded?

If a protein fails multiple folding attempts, it is marked for degradation through the ERAD pathway and eventually routed to proteasomes for disposal.

Can the calnexin/calreticulin cycle be disrupted in diseases?

Yes, disruptions in this cycle have been observed in various diseases, including Alzheimer's disease and diabetes, where improper glycoprotein folding can contribute to pathogenesis.

How does UGGT re-glucosylate proteins?

UGGT transfers a glucose moiety from UDP-Glc to the N-glycan of the protein, effectively resetting it for another round of calnexin/calreticulin binding and folding attempts.

What role do chaperone proteins play in this cycle?

Chaperone proteins like calnexin and calreticulin provide a stable environment for protein folding by maintaining the correct conformation of nascent polypeptides until they are fully folded or marked for degradation.

Try it live

Everything above runs in your browser — open Calnexin/Calreticulin Cycle: N-Glycan Quality Control and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Calnexin/Calreticulin Cycle: N-Glycan Quality Control simulation

The Calnexin/Calreticulin Cycle: Ensuring Glycoprotein Quality in the Endoplasmic Reticulum